Evidence map›Paper›PMID 28274256›Full record

SynthesisMicrobiome2017

Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis.

Mohan Pammi, Julia Cope, Phillip I Tarr, Barbara B Warner, Ardythe L Morrow, Volker Mai, Katherine E Gregory, J Simon Kroll, Valerie McMurtry, Michael J Ferris and 5 more

2 registry-linked trialsOpen access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Microbiome, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 429 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
429citing papers in PubMed, 6 pooled it
32.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03554278 completednot on this mapstarted 2018, after this paper: background citation

Alteration of Stool Microbiota in Preterm Infants Less Than 32 Weeks With Anemia, and Following Blood Transfusion

TypeobservationalSponsorUniversity of Texas Southwestern Medical CenterRan2018 to 2023Enrolled57ConditionsAnemia, Neonatal, Necrotizing Enterocolitis, Dysbiosis
NCT07233382 naactive not recruitingnot on this mapstarted 2026, after this paper: background citation

Assessing the Efficacy of Probiotics in Prevention of NEC in Preterm Babies

TypeinterventionalSponsorHayatabad Medical ComplexRan2026 to 2026Enrolled196ConditionsNEC, NEC - Necrotizing EnterocolitisArmsProbiotic, 10% dextrose
3 · Its place in the literature

Who cites it

429 citing papers in PubMed, 6 syntheses or guidelines pooled it, 685 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Review
  10. Definitions of neonatal Necrotizing Enterocolitis (NEC) in randomised controlled trials: a systematic review.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

369 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Mohan PammiSection of Neonatology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, 77030, Houston, TX, USA. mohanv@bcm.edu.ORCID 0000-0002-5571-6239
Julia CopeAlkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, TX, USA.
Phillip I TarrDepartment of Pediatrics, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Barbara B WarnerDepartment of Pediatrics, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Ardythe L MorrowDepartment of Pediatrics, Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Ohio, USA.
Volker MaiDepartment of Epidemiology, College of Public Health and Health Professions and College of Medicine and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA.
Katherine E GregoryDepartment of Newborn Medicine, Brigham and Women's Hospital, Boston, MA, USA.
J Simon KrollDepartment of Medicine, Section of Paediatrics, Imperial College London, London, UK.
Valerie McMurtryDepartment of Microbiology, Immunology and Parasitology, Children's Hospital, New Orleans, LA, USA.
Michael J FerrisDepartment of Microbiology, Immunology and Parasitology, Children's Hospital, New Orleans, LA, USA.
Lars EngstrandDirector of Clinical Genomics and Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
Helene Engstrand LiljaDepartment of Women's and Children's Health, Uppsala University, 751 85, Uppsala, Sweden.
Emily B HollisterTexas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA.
James VersalovicTexas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA.
Josef NeuSection of Neonatology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, 77030, Houston, TX, USA.
Baylor College of Medicine · USChildren's Hospital of New Orleans · USWashington University in St. Louis · USBrigham and Women's Hospital · USCincinnati Children's Hospital Medical Center · USImperial College London · GBKarolinska Institutet · SEUniversity of Florida · USUppsala University · SE

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
The Neonatal Microbiome and Necrotizing EnterocolitisUH3AI083265 · NIAID · WASHINGTON UNIVERSITY · PI TARR, PHILLIP I · 2010 to 2012
$7.6M
Novel genetic and salivary glycan biomarkers for risk of NEC in ELBW infants.R01HD059140 · NICHD · CINCINNATI CHILDRENS HOSP MED CTR · PI MORROW, ARDYTHE L · 2009 to 2013
$3.3M
Biochemical Predictors of Necrotizing EnterocolitisK23NR011320 · NINR · BOSTON COLLEGE · PI GREGORY, KATHERINE ELIZABETH · 2009 to 2011
$387k
NCRR NIH HHS UL1 RR024992NCRR NIH HHS UL1 RR025758NIAID NIH HHS UH3 AI083265NICHD NIH HHS R01 HD059140NIDDK NIH HHS P30 DK052574NINR NIH HHS K23 NR011320
6 · The paper itself

Abstract

backgroundNecrotizing enterocolitis (NEC) is a catastrophic disease of preterm infants, and microbial dysbiosis has been implicated in its pathogenesis. Studies evaluating the microbiome in NEC and preterm infants lack power and have reported inconsistent results. METHODS AND

resultsOur objectives were to perform a systematic review and meta-analyses of stool microbiome profiles in preterm infants to discern and describe microbial dysbiosis prior to the onset of NEC and to explore heterogeneity among studies. We searched MEDLINE, PubMed, CINAHL, and conference abstracts from the proceedings of Pediatric Academic Societies and reference lists of relevant identified articles in April 2016. Studies comparing the intestinal microbiome in preterm infants who developed NEC to those of controls, using culture-independent molecular techniques and reported α and β-diversity metrics, and microbial profiles were included. In addition, 16S ribosomal ribonucleic acid (rRNA) sequence data with clinical meta-data were requested from the authors of included studies or searched in public data repositories. We reprocessed the 16S rRNA sequence data through a uniform analysis pipeline, which were then synthesized by meta-analysis. We included 14 studies in this review, and data from eight studies were available for quantitative synthesis (106 NEC cases, 278 controls, 2944 samples). The age of NEC onset was at a mean ± SD of 30.1 ± 2.4 weeks post-conception (n = 61). Fecal microbiome from preterm infants with NEC had increased relative abundances of Proteobacteria and decreased relative abundances of Firmicutes and Bacteroidetes prior to NEC onset. Alpha- or beta-diversity indices in preterm infants with NEC were not consistently different from controls, but we found differences in taxonomic profiles related to antibiotic exposure, formula feeding, and mode of delivery. Exploring heterogeneity revealed differences in microbial profiles by study and the target region of the 16S rRNA gene (V1-V3 or V3-V5).

conclusionsMicrobial dysbiosis preceding NEC in preterm infants is characterized by increased relative abundances of Proteobacteria and decreased relative abundances of Firmicutes and Bacteroidetes. Microbiome optimization may provide a novel strategy for preventing NEC.

Indexed as

DysbiosisGastrointestinal MicrobiomeBacillotaBacteriaBacteroidesEnterocolitis, NecrotizingFecesHumansInfant, NewbornInfant, PrematureInfant, Premature, DiseasesIntestinesProteobacteriaRNA, Ribosomal, 16SRNA, Ribosomal, 16S16S rRNA sequencingIntestinalMicrobiomeNECNeonatePreterm

Identifiers

PMID28274256
PMCPMC5343300
OpenAlexW2592537218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.